MyMD Pharmaceuticals Inc (MYMD)

[knuts4oe]

On 7/26/22 MYMD Pharma announced they were advancing the Healthy Lifespan Phase 2 Trial from the 1st cohort (600 mg) to the next cohort (750 mg). As of today we have not had any info from the 2nd active Phase 2 study, Covid 19 induced depression!
It has occurred to me that any success in treating or eliminating said depression would indicate that the same results would likely be true for all forms of "long covid" as all are dependent on chronic inflammation. That result would quickly qualify MYMD-1 for the CTAP (Coronavirus Treatment Acceleration Program) to speed up MYMD-1's availability for use in fighting "long Covid". MYMD's Chief Scientific Officer, Adam Caplin, has been quoted as saying, "The importance of our upcoming Phase 2 trial(Covid 19 induced depression) can't be overstated", and I suspect he was referring to "long Covid" treatment.
Comments welcomed!